Emerging in the arena of weight management therapy, retatrutide represents a distinct method. Beyond many existing medications, retatrutide operates as a double agonist, simultaneously engaging both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) sensors. The concurrent stimulation promotes various advantageous ef